Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 189669, "name": "Kilitch Drugs", "stock_name": "Kilitch Drugs", "full_name": "Kilitch Drugs (India) Ltd", "name_url": "stocks-analysis/kilitch-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "152.50", "chg": -0.3, "chgp": "-0.2%", "dir": -1, "prev_price": "152.80", "mcapval": "552.00 Cr", "mcap": "Micro Cap", "scripcode": 524500, "symbol": "KILITCH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE729D01010", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "52.94 k", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Why is Kilitch Drugs (India) Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-india-ltd-fallingrising-3917601", "imagepath": "", "date": "2026-03-26 01:21:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Over the past week, Kilitch Drugs has underperformed the benchmark Sensex index, registering a decline of 4.39% compared to the Sensex’s 1.87% fall. This underperformance extends to the one-month period, where the stock dropped 4.97%, although this was less severe than the Sensex’s 8.51% decline. Year-to-date, Kilitch Drugs has fallen 13.07%, slightly worse than the Sensex’s 11.67% decrease. Over the last year, the stock’s decline of 12.42% notably outpaces the Sensex’s more modest 3.52% fall. However, the longer-term picture remains positive, with Kilitch Drugs delivering a remarkable 100.26% gain over three years and an impressive 273.77% rise over five years, significantly outperforming the Sensex’s respective 30.85% and 55.39..." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3909636", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3909636.png", "date": "2026-03-24 10:10:41", "description": "Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "What is the bonus history of Kilitch Drugs?", "link": "https://www.marketsmojo.com/news/stocks-in-action/what-is-the-bonus-history-of-kilitch-drugs-3904620", "imagepath": "", "date": "2026-03-20 23:00:54", "description": "Kilitch Drugs has a recent bonus history that includes a 1:1 bonus issue, which is set to take effect on March 24, 2026. This means that for every share held, shareholders will receive an additional share. The record date and ex-date for this bonus issue are both the same, March 24, 2026. If you have any further questions about Kilitch Drugs or its financial activities, feel free to ask!..." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3888312", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3888312.png", "date": "2026-03-13 10:10:43", "description": "Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3863990", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3863990.png", "date": "2026-03-02 10:10:49", "description": "Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Kilitch Drugs Falls 4.43%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-falls-443-3-key-factors-driving-the-weekly-decline-3863222", "imagepath": "", "date": "2026-03-01 13:01:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Stock opens at Rs.322.40, down 2.18% amid broader market gains</p>\n <p><strong>18 Feb:</strong> Price rallies to Rs.330.00 (+1.59%) on mild technical momentum shift</p>\n <p><strong>19 Feb:</strong> Kilitch Drugs upgraded to Sell rating by MarketsMOJO</p>\n <p><strong>20 Feb:</strong> Stock closes week at Rs.315.00, down 1.58% amid bearish technical signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.329.60</div></div>\n <div class=\"stat-item\"><div class=\"stat-l..." }, { "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3847637", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3847637.png", "date": "2026-02-20 08:00:44", "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling increased selling pressure, with the stock price retreating 3.02% on 20 Feb 2026 to ₹320.05, down from the previous close of ₹330.00. Investors and analysts are closely monitoring these developments amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector." }, { "title": "Kilitch Drugs Upgraded to Sell: Comprehensive Analysis of Quality, Valuation, Financial Trend, and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-sell-comprehensive-analysis-of-quality-valuation-financial-trend-and-technicals-3846341", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_mojoScore_3846341.png", "date": "2026-02-19 08:02:54", "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Feb 2026, reflecting a nuanced shift in its valuation and technical outlook despite ongoing financial challenges. The pharmaceutical company’s recent quarterly results and market performance have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals." }, { "title": "Kilitch Drugs (India) Ltd Shows Mixed Technical Signals Amid Mild Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-shows-mixed-technical-signals-amid-mild-momentum-shift-3846204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3846204.png", "date": "2026-02-19 08:00:28", "description": "Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bearish stance to a more mildly bearish or mixed outlook. Despite a modest day gain of 1.59%, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector." } ], "total": 294, "sid": "189669", "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669" }, "announcements": [ { "caption": "Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "17-Mar-2026", "details": "We hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM", "datetime": "13-Mar-2026", "details": "We hereby submit proceeding of EGM", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "13-Mar-2026", "details": "We are submitting herewith the Scrutinizers Report", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19", "dt": "2019-09-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26", "dt": "2026-03-24", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25", "dt": "2025-07-15", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

16 Feb: Stock opens at Rs.322.40, down 2.18% amid broader market gains

18 Feb: Price rallies to Rs.330.00 (+1.59%) on mild technical momentum shift

19 Feb: Kilitch Drugs upgraded to Sell rating by MarketsMOJO

20 Feb: Stock closes week at Rs.315.00, down 1.58% amid bearish technical signals

Week Open

Rs.329.60

Read full news article

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-02-20 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling increased selling pressure, with the stock price retreating 3.02% on 20 Feb 2026 to ₹320.05, down from the previous close of ₹330.00. Investors and analysts are closely monitoring these developments amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs Upgraded to Sell: Comprehensive Analysis of Quality, Valuation, Financial Trend, and Technicals

2026-02-19 08:02:54

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Feb 2026, reflecting a nuanced shift in its valuation and technical outlook despite ongoing financial challenges. The pharmaceutical company’s recent quarterly results and market performance have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Kilitch Drugs (India) Ltd Shows Mixed Technical Signals Amid Mild Momentum Shift

2026-02-19 08:00:28

Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bearish stance to a more mildly bearish or mixed outlook. Despite a modest day gain of 1.59%, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article